Exclusive

Publication

Byline

Location

US Patent Issued to Ultima Genomics on Oct. 6 for "Methods for preparing a library of polynucleotide molecules" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,405, issued on Oct. 6, was assigned to Ultima Genomics Inc. (Fremont, Calif.). "Methods for preparing a library of polynucleotide molecules"... Read More


US Patent Issued to The Broad Institute, Massachusetts Institute of Technology on Oct. 6 for "CAS12B enzymes and systems" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,406, issued on Oct. 6, was assigned to The Broad Institute Inc. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Mass... Read More


US Patent Issued to Phio Pharmaceuticals on Oct. 6 for "Chemically modified oligonucleotides targeting bromodomain containing protein 4 (BRD4) for immunotherapy" (Swedish, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,407, issued on Oct. 6, was assigned to Phio Pharmaceuticals Corp. (King of Prussia, Pa.). "Chemically modified oligonucleotides targeting br... Read More


US Patent Issued to STOKE THERAPEUTICS on Oct. 6 for "OPA1 antisense oligomers for treatment of conditions and diseases" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,408, issued on Oct. 6, was assigned to STOKE THERAPEUTICS INC. (Bedford, Mass.). "OPA1 antisense oligomers for treatment of conditions and d... Read More


US Patent Issued to HANGZHOU TIANLONG PHARMACEUTICAL on Oct. 6 for "Double-stranded RNAi agents for targeting and regulating HBV gene expression, and a use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,409, issued on Oct. 6, was assigned to HANGZHOU TIANLONG PHARMACEUTICAL Co. LTD. (Hangzhou, China). "Double-stranded RNAi agents for targeti... Read More


US Patent Issued to TIANJIN MEDICAL UNIVERSITY on Oct. 6 for "FATS as a target for treating tumors and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,410, issued on Oct. 6, was assigned to TIANJIN MEDICAL UNIVERSITY (Tianjin, China). "FATS as a target for treating tumors and uses thereof" ... Read More


US Patent Issued to The Brigham and Women's Hospital on Oct. 6 for "Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,411, issued on Oct. 6, was assigned to The Brigham and Women's Hospital Inc. (Boston). "Gene therapy for neurodegenerative disorders using p... Read More


US Patent Issued to The Regents of the University of California, The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Gladstone on Oct. 6 for "Compositions and methods for modifying a target nucleic acid" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,412, issued on Oct. 6, was assigned to The Regents of the University of California (Oakland, Calif.) and The J. David Gladstone Institutes, A... Read More


US Patent Issued to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION on Oct. 6 for "RNA guide genome editing in citrus using CRISPR-ribonucleoprotein complexes" (Florida Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,413, issued on Oct. 6, was assigned to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION Inc. (Gainesville, Fla.). "RNA guide genome editing in citr... Read More


US Patent Issued to GAT BIOSCIENCES on Oct. 6 for "Vector for co-expressing genes of interest" (Spanish Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,414, issued on Oct. 6, was assigned to GAT BIOSCIENCES S.L. (Barcelona, Spain). "Vector for co-expressing genes of interest" was invented by... Read More